Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Apollo Pharmacies Limited is a leading retail pharmacy chain in India that offers pharmaceutical products and healthcare services. It provides a wide range of medications, health supplements, and wellness products, along with services such as health check-ups and consultations, addressing diverse customer needs in the healthcare sector.
Apollo Pharmacies Limited, is an unlisted public company incorporated on 08 July, 2016. It is classified as a public limited company and is located in , Tamil Nadu. It's authorized share capital is INR 145.00 cr and the total paid-up capital is INR 143.50 cr.
Read more
** All rupee values in INR crores. Based on March 2025 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Mrinalini Reddy Chigullarevu | 08998057 | 5 years |
| Managing Director | Singana Obul Reddy | 00027829 | 10 years |
| Director | Ethiraj Panneerselvam | 08854640 | 6 years |
| Nominee Director | Venkata Chalam Durvasula | 02749496 | 5 years |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales | 5,608.5 | 6,755.2 | 8,258.8 | 9,927.6 | 11,544.4 |
| Operating profit | 280.0 | 254.3 | 125.1 | 228.3 | 396.3 |
| Net profit | 18.3 | -27.3 | -282.4 | -176.8 | -194.4 |
| Gross margin | 20.3 | 19.7 | 19.5 | 20.3 | 20.4 |
| Operating margin | 5.0 | 3.8 | 1.5 | 2.3 | 3.4 |
| Net margin | 0.3 | -0.4 | -3.4 | -1.8 | -1.7 |
| Networth | 155.4 | 124.0 | -159.0 | -334.7 | -532.5 |
| Borrowings | 455.8 | 235.0 | 380.6 | 507.4 | 619.9 |
| Assets | 2,137.4 | 2,496.6 | 3,710.9 | 4,314.1 | 5,064.8 |
| Debt to equity | 2.9 | 1.9 | -2.4 | -1.5 | -1.2 |
| Current ratio | 1.0 | 0.9 | 0.7 | 0.6 | 0.5 |
| ROE | 11.8 | -22.0 | - | - | - |
| Days payable | 42.0 | 60.0 | 84.0 | 82.0 | 85.0 |
| WC days | 0.0 | -6.0 | -28.0 | -42.0 | -52.0 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 143.5 | 143.5 | 143.5 | 143.5 | 143.5 |
| Reserves | 11.9 | -19.5 | -302.5 | -478.2 | -676.0 |
| Borrowings + | 455.8 | 235.0 | 380.6 | 507.4 | 619.9 |
| Long term borrowings | 226.2 | 217.0 | 186.9 | 141.2 | 85.7 |
| Short term borrowings | 229.6 | 18.0 | 193.7 | 366.2 | 534.2 |
| Trade payables + | 517.5 | 888.4 | 1,526.5 | 1,770.2 | 2,139.1 |
| Days payable | 42.0 | 60.0 | 84.0 | 82.0 | 85.0 |
| Other liabilities + | 1,008.7 | 1,249.2 | 1,962.8 | 2,371.2 | 2,838.3 |
| Other non-current liabilities | 748.5 | 926.6 | 1,501.9 | 1,874.3 | 2,302.1 |
| Other current liabilities | 260.2 | 322.6 | 460.9 | 496.9 | 536.2 |
| Total liabilities | 2,137.4 | 2,496.6 | 3,710.9 | 4,314.1 | 5,064.8 |
| Fixed Assets + | 966.5 | 1,179.3 | 1,909.9 | 2,400.5 | 2,957.9 |
| Tangible assets | 942.9 | 1,141.4 | 403.1 | 562.5 | 747.4 |
| CWIP | 4.9 | 16.9 | 1,471.3 | 1,798.3 | 2,169.4 |
| Intangible assets | 18.7 | 21.0 | 35.5 | 39.7 | 41.1 |
| LT loans and advances | - | - | - | - | - |
| Other non-current assets | 160.7 | 199.6 | 250.7 | 419.5 | 527.5 |
| Current assets + | 1,010.2 | 1,117.7 | 1,550.3 | 1,494.1 | 1,579.4 |
| Inventories | 643.9 | 785.0 | 1,032.9 | 1,130.2 | 1,221.9 |
| Trade receivables | 170.2 | 227.8 | 261.7 | 211.6 | 185.0 |
| Cash and cash equivalents | 144.4 | 54.2 | 66.5 | 57.8 | 83.3 |
| ST loans and advances | - | - | - | - | - |
| Other current assets | 51.7 | 50.6 | 189.2 | 94.5 | 89.2 |
| Total assets | 2,137.4 | 2,496.6 | 3,710.9 | 4,314.1 | 5,064.8 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Sales + | 5,608.5 | 6,755.2 | 8,258.8 | 9,927.6 | 11,544.4 |
| Sales growth % | None | 20.45 | 22.26 | 20.21 | 16.29 |
| Expenses + | 5,585.2 | 6,795.7 | 8,557.5 | 10,241.5 | 11,804.3 |
| Cost of goods | 4,470.6 | 5,421.7 | 6,647.3 | 7,911.3 | 9,192.4 |
| Employee cost | 550.7 | 663.6 | 850.6 | 982.9 | 1,126.9 |
| Other costs | 307.2 | 415.6 | 635.8 | 805.1 | 828.8 |
| Operating profit + | 280.0 | 254.3 | 125.1 | 228.3 | 396.3 |
| Operating margin % | 5.0 | 3.8 | 1.5 | 2.3 | 3.4 |
| Other income | 0.3 | 1.4 | 1.7 | 1.4 | 1.1 |
| Interest | 102.4 | 119.1 | 179.7 | 240.9 | 295.1 |
| Depreciation | 154.3 | 175.7 | 244.1 | 301.3 | 361.1 |
| Exceptional items | - | - | - | - | - |
| Profit before tax | 23.7 | -39.0 | -297.0 | -312.5 | -258.8 |
| Tax | 5.3 | -11.7 | -14.6 | -135.7 | -64.4 |
| Profit - disc. ops | - | - | - | - | - |
| Net profit | 18.3 | -27.3 | -282.4 | -176.8 | -194.4 |
| Net margin % | 0.3 | -0.4 | -3.4 | -1.8 | -1.7 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | 2.9 | 1.9 | -2.4 | -1.5 | -1.2 |
| Net Debt/Equity | 2.0 | 1.5 | -2.0 | -1.3 | -1.0 |
| Total Debt/Assets | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Total Assets/Equity | 13.8 | 20.1 | -23.3 | -12.9 | -9.5 |
| Liquidity + | |||||
| Current Ratio | 1.0 | 0.9 | 0.7 | 0.6 | 0.5 |
| Quick Ratio | 0.4 | 0.3 | 0.2 | 0.1 | 0.1 |
| Interest Coverage | 2.7 | 2.1 | 0.7 | 0.9 | 1.3 |
| Performance | |||||
| Gross Margin | 20.3 | 19.7 | 19.5 | 20.3 | 20.4 |
| Operating Margin | 5.0 | 3.8 | 1.5 | 2.3 | 3.4 |
| Net Margin | 0.3 | -0.4 | -3.4 | -1.8 | -1.7 |
| Return + | |||||
| Return on Equity | 11.8 | -22.0 | - | - | - |
| Pre-tax ROCE | 13.0 | 7.4 | -9.3 | -5.8 | 2.6 |
| Return on Assets | 0.9 | -1.1 | -7.6 | -4.1 | -3.8 |
| Pre-tax ROIC | 26.9 | 25.8 | -76.7 | -63.5 | 858.5 |
| Efficiency + | |||||
| Days Payable | 42.0 | 60.0 | 84.0 | 82.0 | 85.0 |
| Days Inventory | 53.0 | 53.0 | 57.0 | 52.0 | 49.0 |
| Days Receivable | 11.0 | 12.0 | 12.0 | 8.0 | 6.0 |
| Fixed Asset Turnover | 5.8 | 5.7 | 4.3 | 4.1 | 3.9 |
| Total Asset Turnover | 2.6 | 2.7 | 2.2 | 2.3 | 2.3 |
| Working Capital | |||||
| Cash Conversion Cycle | 22.0 | 5.0 | -15.0 | -22.0 | -30.0 |
| Working Capital Days | 0.0 | -6.0 | -28.0 | -42.0 | -52.0 |
Axis Bank Limited
No. of Loans: 2
Total Amount : 466.5 cr
IndusInd Bank Limited
No. of Loans: 1
Total Amount : 400.0 cr
DBS BANK INDIA LIMITED
No. of Loans: 1
Total Amount : 300.0 cr
State Bank of India
No. of Loans: 1
Total Amount : 125.0 cr
Read more
The incorporation date of APOLLO PHARMACIES LIMITED is 08 July, 2016
The authorized share capital of APOLLO PHARMACIES LIMITED is INR ₹ 145.0 Cr.
The paid-up capital of APOLLO PHARMACIES LIMITED is INR ₹ 143.5 Cr.
The registered address of APOLLO PHARMACIES LIMITED is No.19, Bishop Gardens, Rajaannamalai puram, Chennai, Chennai, Tamil Nadu, India, 600028 - 600028
The CIN number of APOLLO PHARMACIES LIMITED is U52500TN2016PLC111328.